{"id":"engerix-b-and-twinrix","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Injection site soreness, redness, or swelling"},{"rate":"10-15","effect":"Fatigue"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Myalgia"},{"rate":"1-5","effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Engerix-B is a recombinant hepatitis B vaccine that contains hepatitis B surface antigen (HBsAg) produced in yeast cells, which triggers B-cell and T-cell responses to generate protective antibodies. Twinrix is a combination vaccine containing both hepatitis A inactivated virus and hepatitis B recombinant surface antigen, providing dual protection against both viruses through similar immune mechanisms.","oneSentence":"These vaccines stimulate the immune system to produce antibodies against hepatitis A and/or B viruses, providing protective immunity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:42:22.982Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis B infection"},{"name":"Prevention of hepatitis A and B infection (Twinrix)"}]},"trialDetails":[{"nctId":"NCT02985450","phase":"","title":"A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2016-08","conditions":"Non-Alcoholic Fatty Liver Disease, Hepatitis B, Vaccine Reaction","enrollment":82},{"nctId":"NCT00289731","phase":"PHASE4","title":"Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-11-24","conditions":"Hepatitis B, Hepatitis A","enrollment":596},{"nctId":"NCT01037114","phase":"PHASE4","title":"Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-01-27","conditions":"Hepatitis A, Hepatitis B","enrollment":50},{"nctId":"NCT01000324","phase":"PHASE4","title":"Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11-06","conditions":"Hepatitis A, Hepatitis B","enrollment":44},{"nctId":"NCT00289744","phase":"PHASE3","title":"Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-02-16","conditions":"Hepatitis B, Hepatitis A","enrollment":178},{"nctId":"NCT00684671","phase":"PHASE4","title":"Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-05-26","conditions":"Hepatitis A, Hepatitis B","enrollment":506},{"nctId":"NCT00106964","phase":"PHASE4","title":"Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2004-01","conditions":"HIV Infection, Hepatitis B","enrollment":371},{"nctId":"NCT00603252","phase":"PHASE4","title":"Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-01","conditions":"Hepatitis B, Hepatitis A","enrollment":213},{"nctId":"NCT00142753","phase":"PHASE4","title":"Immunologic Memory (Supp. of ATN 024)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2005-08","conditions":"HIV Infections","enrollment":95},{"nctId":"NCT00244374","phase":"NA","title":"A Randomized Trial of Vaccine Adherence in Young Injection Drug Users","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2004-08","conditions":"Medication Adherence, Substance Abuse, Intravenous, Risk Behavior","enrollment":546},{"nctId":"NCT00186836","phase":"PHASE4","title":"Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients","status":"COMPLETED","sponsor":"St. Joseph's Health Care London","startDate":"2004-11","conditions":"Hepatitis B","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":30,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Engerix-B and Twinrix","genericName":"Engerix-B and Twinrix","companyName":"St. Joseph's Health Care London","companyId":"st-joseph-s-health-care-london","modality":"Biologic","firstApprovalDate":"","aiSummary":"These vaccines stimulate the immune system to produce antibodies against hepatitis A and/or B viruses, providing protective immunity. Used for Prevention of hepatitis B infection, Prevention of hepatitis A and B infection (Twinrix).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}